We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04264143
Recruitment Status : Recruiting
First Posted : February 11, 2020
Last Update Posted : March 10, 2022
Midatech Pharma US Inc.
Information provided by (Responsible Party):
Luca Szalontay, Columbia University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2023
Estimated Study Completion Date : February 2024